Sanofi-Aventis appoints Zentiva's GM in Poland
This article was originally published in Scrip
Sanofi-Aventis has appointed Janusz Gaudnik general manager of the Polish branch of its subsidiary Zentiva. Zentiva produces generic pharmaceuticals and is well established in the countries of central and eastern Europe, including ex-Soviet republics. Mr Gaudnik's most recent position was GM of Servier's branch in Ireland. He also led Servier's division in Slovakia from 2006-2008 and was deputy manager of Servier's operations in CEE from 2004-2006. Sanofi-Aventis has more than 1,300 employees in Poland including 190 at a production facility in Rzeszow.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.